Measurement of the Glial Fibrillary Acidic Protein and Its Breakdown Products GFAP-BDP Biomarker for the Detection of Traumatic Brain Injury Compared to Computed Tomography and Magnetic Resonance Imaging

Glial fibrillary acidic protein and its breakdown products (GFAP-BDP) are brain-specific proteins released into serum as part of the pathophysiological response after traumatic brain injury (TBI). We performed a multi-center trial to validate and characterize the use of GFAP-BDP levels in the diagno...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Neurotrauma
Autors principals: McMahon, Paul J., Panczykowski, David M., Yue, John K., Puccio, Ava M., Inoue, Tomoo, Sorani, Marco D., Lingsma, Hester F., Maas, Andrew I.R., Valadka, Alex B., Yuh, Esther L., Mukherjee, Pratik, Manley, Geoffrey T., Okonkwo, David O., Casey, Scott S., Cheong, Maxwell, Cooper, Shelly R., Dams-O'Connor, Kristen, Gordon, Wayne A., Hricik, Allison J., Lawless, Kerri, Menon, David, Schnyer, David M., Vassar, Mary J.
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2015
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4394160/
https://ncbi.nlm.nih.gov/pubmed/25264814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/neu.2014.3635
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars